PFE

$PLTR and the following are parked to move much higher tomorrow into the week and beyond - $NKE $MNTS $PFE $SPY

$PFE This one pays nearly a 7% annual dividend. Ex-dividend date will be sometime in August. Another reason to be bullish.

$LLY Oncology Head confirmed they have a pile of cash & ZERO arbitrary limits on deal size for de-risked assets with solid human data. If the science delivers, they want in. Cash is NO problem! BOOM! Which brings us back to this: Stop calling for a "2-week lag" after the 80th event. $SLS 8-K calendar blueprint proves otherwise: • Dec '25: Cut-off Fri 12/26 > 8-K Mon 12/29 (1 biz day!) • May '26: Cut-off Mon 5/11 > 8-K Tue 5/12 (24-hr turnaround!) The old lag is DEAD! Continuous CRO scrubbing & AI-driven capture mean validation takes HOURS. Zero May deaths is mathematically impossible for late-stage AML. Following the 23-day cadence, the 79th hit mid-May, putting the 80th right now—on pace for a late June/early July announcement. With a tiny ~196M share count, a $10.5B GSK-style buyout puts the stock at $53.40. Factor in the full WT1 platform/SLS-009 at $20B shares hit $101.71+ before pricing in the massive short squeeze and scrambling funds. $PFE $MRK $ABBV https://www.youtube.com/watch?v=t93lYkzLQMU&t=481s

$PFE is fighting to reclaim the 200-SMA (on weekly) , and that's the only technical signal that matters for the long-term trend. We’ve seen three weeks of strong accumulation, and the institutional bid is finally outweighing the selling pressure. If we clear $27, we’re back in bull territory. 🐂 Bull Level: Reclaim $27.00 to confirm the move toward $29.00+. 🐻 Bear Level: $25.50 is the non-negotiable floor for this breakout. #PFE #Pfizer #Dividends #ValueInvesting #hovdid